Indian Pharma Industry: An Investment Opportunity - Expected to grow over 15 per cent per annum between 2015 and 2020, Pharmaceutical Unit (Tablet, Capsules & Syrup) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics, Production Schedule, Working Capital Requirement, Plant Layout, Process Flow Sheet, Cost of Project, Projected Balance Sheets, Profitability Ratios, Break Even Analysis

The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. India enjoys an important position in the global pharmaceuticals sector.

The Department of Pharmaceuticals has a Vision for the development of the IndianPharmaceutical Industry.  This Vision is –  

“To make India the Largest Global Provider of Quality Medicines at Reasonable Prices.”

The Vision is to be achieved as per the following Mission:

·         Develop Human Resources for Pharmaceutical Industry and Drug Research and Development

·         Promote Public‐Private Partnership for development of pharmaceuticals Industry

·         Promote Pharma Brand India through International Cooperation

·         Promote environmentally sustainable development of Pharmaceutical Industry

·         Enable availability, accessibility and affordability of drugs  

Pharmaceutical companies in India both Indian and foreign, manufacture bulk drugs in several therapeutic categories and the industry has facilities to manufacture various types of dosage namely capsule, tablets, injectable, orals, and liquids. The industry today can boast of producing the entire range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations.

According to the Federation of Indian Chambers of Commerce and Industry (FICCI), another apex industry association, there are some 6,000 firms engaged in the sector. In terms of revenue generation, there are 100 big companies (including subsidiaries of MNCs) each with sales of at least USD 650,000, 200 medium size companies with sales ranging between USD 210,400 and USD 650,000; and 5700 small companies with sales of less than USD 210,400. Because many of these companies focus on producing similar generic or same drugs, the industry is characterized by fierce competition and high volumes, razor-thin profit margins, overcapacity, and declining prices.

The growth has been driven by many factors, such as legislative reforms, growth in contract manufacturing and outsourcing, value added foreign acquisitions and joint ventures and India's acu-men and expertise in reverse engineering of patented drug molecules. India has, in the meantime, been trying to comply with the World Trade Organization's Trade Related Intellectual Property Agreement (TRIPs) obligations.

The Indian pharma industry, which is expected to grow over 15 per cent per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same period!. The market is expected to grow to US$ 55 billion by 2020.

Few Indian Major Players are as under

• A Tosh & Sons (India) Ltd.
• Aarti Industries Ltd.
• Agio Pharmaceuticals Ltd.
• Alintosch Pharmaceuticals Ltd.
• Anil Bioplus Ltd.
• Anil Starch Products Ltd.
• Astrix Laboratories Ltd.
• B A & Brothers (Eastern) Ltd.
• Caldern Pharmaceuticals Ltd.
• ExpicorPharma Pvt. Ltd.
• Fem Care Pharma Ltd.
• German Remedies Ltd.
• HiranOrgochem Ltd.
• Kedia Chemicals Inds. Ltd.
• KunshanRotam Reddy Pharmaceutical Co. Ltd.
• Larite Industries Ltd.
• Lyka Labs Ltd.
• Max Healthcare Institute Ltd.
• Midas Pharmasec Ltd.
• N G L Fine-Chem Ltd.
• Norris Medicines Ltd.
• Sanofi India Ltd.
• Sayaji Industries Ltd.
• Stellar Exports Ltd.
• Suyash Laboratories Ltd.
• United Breweries (Holdings) Ltd.
• Vellanova Pharmaceuticals Ltd.
• Vera Pharma Ltd.
• Vivo Bio Tech Ltd.
• Winmac Laboratories Ltd.
• Yogi Pharmacy Ltd.

See more

https://goo.gl/yvJ4MC

https://goo.gl/iCteYS

https://goo.gl/t3xHgb

Contact us

Niir Project Consultancy Services

106-E, Kamla Nagar, Opp. Spark Mall,

New Delhi-110007, India.

Email: [email protected], [email protected]     

Tel: +91-11-23843955, 23845654, 23845886, 8800733955

Mobile: +91-9811043595

Fax: +91-11-23841561

Website : www.entrepreneurindia.co , www.niir.org